JHX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
James Hardie Industries PLC (JHX) is not a strong buy at the moment for a beginner investor with a long-term focus. While there are positive catalysts such as hedge fund buying and bullish analyst ratings, the company's recent financial performance, including a significant drop in net income and EPS, raises concerns. Additionally, technical indicators are mixed, and there are no strong proprietary trading signals to support an immediate buy decision. Holding or waiting for further clarity may be a better approach.
The technical indicators are mixed. While moving averages are bullish (SMA_5 > SMA_20 > SMA_200), the MACD is negatively expanding (-0.108), and the RSI is neutral at 50.277. The stock is trading near its key support level (S1: 24.464), which could act as a floor, but there is no strong upward momentum currently.
Hedge funds are significantly increasing their positions, with a 224.32% increase in buying over the last quarter.
Analysts have raised price targets significantly, with JPMorgan upgrading the stock to Overweight and projecting strong earnings growth in fiscal 2027 and
The premium siding category remains attractive, as noted by Barclays.
Financial performance in Q3 2026 shows a significant decline in net income (-51.52% YoY) and EPS (-63.64% YoY), despite revenue growth.
Gross margin dropped to 36.15%, down 4.92% YoY, indicating cost pressures.
No recent news or event-driven catalysts to support immediate upward momentum.
In Q3 2026, revenue increased by 30.05% YoY to $1.24 billion, but net income dropped significantly by 51.52% YoY to $68.7 million. EPS also fell by 63.64% YoY to $0.12, and gross margin declined to 36.15%, down 4.92% YoY. These results suggest strong top-line growth but significant profitability challenges.
Analysts are generally positive on JHX. Barclays raised its price target to $26, Baird to $32, and JPMorgan to A$41.50, with upgrades to Overweight and Buy ratings. Analysts highlight strong fiscal Q3 results, cost synergies, and long-term growth potential, but note a conservative Q4 outlook.
